Xtant Medical to Issue First Quarter 2025 Financial Results on May 12, 2025
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Xtant Medical Holdings (NYSE American: XTNT), a global medical technology company specializing in surgical solutions for spinal, orthopedic, and woundcare disorders, has scheduled its first quarter 2025 financial results announcement for May 12, 2025, after market close.
The company will host a conference call at 4:30 PM ET on the same day, featuring President and CEO Sean Browne and CFO Scott Neils. Investors can access the call via domestic (888-506-0062) or international (973-528-0011) dial-in numbers using passcode 828748. A webcast replay will be available on the company's website afterward.
Details
News Market Reaction – XTNT
The recorded move for XTNT in the trading session of this news was +1.23%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Monday, May 12, 2025 at 4:30 PM ET to review results.
Conference Details:
Conference Date: Monday, May 12, 2025
Conference Time: 4:30 PM ET
Conference dial-in: 888-506-0062
International dial-in: 973-528-0011
Passcode: 828748
Conference Call Name: Xtant Medical Q1 2025 Financial Results
Webcast Link: https://www.webcaster4.com/Webcast/Page/3039/52428
Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor Info."
About Xtant Medical Holdings, Inc.
Xtant Medical's mission of "honoring the gift of donation so that our patients can live as full and complete a life as possible" is the driving force behind our company. Xtant Medical Holdings, Inc. ( www.xtantmedical.com ) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in
View original content:https://www.prnewswire.com/news-releases/xtant-medical-to-issue-first-quarter-2025-financial-results-on-may-12-2025-302447175.html
SOURCE Xtant Medical Holdings, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.